MEMajd F. Ellauzi

Majd F. Ellauzi

*This is an algorithmically generated author record based on publicly available information.

Majd F. Ellauzi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Natural Phenolic Compounds in Pain Management and Regenerative Medicine: From Molecular Mechanisms to Therapeutic Applications

    by Duaa Abuarqoub, Alqassem H. Abuarqoub, Mais Emad, Majd F. Ellauzi, Pascal A. Hattar

    Natural phenolic compounds are plant-derived compounds known for their potent antioxidant and anti-inflammatory properties. In addition, natural phenolic compounds are being investigated for their potential applications in pain management, and tissue engineering and regenerative medicine. This review aims to emphasize the anti-inflammatory and anti-oxidant effects of natural phenolic compounds and to highlight their important roles in pain management and tissue engineering and regenerative medicine. In pain management, natural phenolic compounds demonstrated promising results in suppressing orofacial, pelvic, neuropathic, and musculoskeletal pain compared to conventional pain management drugs or by synergistically acting with those drugs. While in tissue engineering and regenerative medicine, natural phenolic compounds were found to enhance the differentiation potential of stem cells into different lineages by increasing the expression of differentiation markers and were also found to enhance proliferation and migration of different types of dental stem cells. In conclusion, natural phenolic compounds, due to their unique properties, are promising in protocols of pain management as well as in tissue engineering and regenerative medicine.

  • Open Access

    Bioprinting the Craniofacial Region: A New Era in Regenerative Medicine and Dentistry

    by Duaa Abuarqoub, Mais Emad, Alqassem H. Abuarqoub, Majd F. Ellauzi, Tala Maragha

    Background: Three-dimensional (3D) printing and bioprinting have emerged as transformative technologies in tissue engineering and regenerative medicine. Conventional 3D printing enables the fabrication of complex, customizable scaffolds that mimic the native extracellular matrix (ECM), providing mechanical support essential for cell adhesion, proliferation, and differentiation. In contrast, 3D bioprinting integrates biomaterials, growth factors, and living cells into bioinks, allowing the precise layer-by-layer construction of tissue-like structures. Objective: This review aims to highlight recent advances and applications of both conventional 3D printing and 3D bioprinting in regenerative medicine, with a specific focus on craniofacial tissue regeneration. Particular emphasis is placed on the distinct roles of scaffold-based and cell-laden approaches. Methods: A comprehensive analysis of the current literature was conducted to examine both conventional 3D printing and bioprinting approaches used in craniofacial tissue engineering. Emphasis was placed on printing techniques, bioink composition and selection, scaffold design, and cell sources, as well as their applications across multiple tissue types. Results: Recent developments demonstrate that conventional 3D printing enables the fabrication of customizable scaffolds, whereas 3D bioprinting enables the generation of highly organized, cell-laden constructs that closely resemble native tissue architecture. These technologies have shown promising outcomes in developing patient-specific disease models and regenerative implants for craniofacial tissues, including bone, dental, tracheal, ocular, muscle, and neural tissues. Conclusions: 3D printing and bioprinting offer powerful platforms for craniofacial regenerative medicine. Ongoing advancements in bioink formulation, printing precision, and biological integration are expected to further enhance their translational and clinical potential.